Regulation of Blood Vessel Formation and Cell-Cell Adhesion By PCDHGB4

Target Name: PCDHGB4

NCBI ID: G8641

PCDHGB4

Regulation of Blood Vessel Formation and Cell-Cell Adhesion By PCDHGB4

Fibroblast cadherin (Fc) is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and connective tissues. It is a transmembrane protein that is involved in cell-cell adhesion and signaling. One of its functions is to regulate the formation of new blood vessels, which is important for wound healing and tissue regeneration.

PCDHGB4 is a gene that encodes for the protein known as Fibroblast cadherin (Fc). This gene is located on chromosome 16 and has been implicated in the development and progression of various diseases, including cancer.

One of the functions of PCDHGB4 is to regulate the formation of new blood vessels. This is important for the growth and development of tissues, including organs. In addition, PCDHGB4 is also involved in the regulation of cell-cell adhesion and signaling. This is important for the development and maintenance of tissues and organs, including the nervous system and the circulatory system.

PCDHGB4 has also been shown to be involved in the regulation of cellular processes that are important for cancer development. For example, studies have shown that PCDHGB4 can promote the growth and survival of cancer cells. In addition, PCDHGB4 has also been shown to contribute to the development of metastasis, which is the ability of cancer cells to spread to other parts of the body.

Due to its involvement in these processes, PCDHGB4 has been identified as a potential drug target for the treatment of various diseases, including cancer. Studies have shown that targeting PCDHGB4 with small molecules or antibodies has the potential to inhibit its function and reduce the growth and spread of cancer cells.

In addition to its potential as a drug target, PCDHGB4 has also been shown to be a potential biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that PCDHGB4 levels are elevated in various tissues and fluids, including the blood, urine, and placenta, which can be used as a diagnostic marker for certain diseases. In addition, PCDHGB4 levels have also been shown to be associated with the outcomes of various therapies, including cancer treatments.

Overall, PCDHGB4 is a protein that is involved in a variety of important functions in the body. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for various diseases. Further research is needed to fully understand the role of PCDHGB4 in these processes and to develop effective treatments.

Protein Name: Protocadherin Gamma Subfamily B, 4

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHGB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHGB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets